Status:
COMPLETED
Fascial Release on Upper Cross Syndrome.
Lead Sponsor:
Cairo University
Conditions:
Upper Cross Syndrome
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
This study will be a randomized controlled trial conducted to investigate the effect of release of upper track of deep front fascial line on patients with Upper Cross Syndrome.A sample size of 40 will...
Detailed Description
Upper Cross Syndrome is a characterized by muscular imbalance of skeletal muscles activation and inhibition rather than just single muscle involvement. Individuals who present with upper crossed syndr...
Eligibility Criteria
Inclusion
- Age ranged from 18 to 40 years.
- Body Mass Index ≤30 kg/m².
- All participants have forward head ,craniovertebral angle less than 48-50 degrees.
- All participants have round back(kyphosis angle ≥ 42°).
- The subjects were chosen from both genders.
- Based on assessment for upper cross syndrome by photogrammetric analysis
Exclusion
- History of trauma or surgery in cervical region.
- Bone fractures or acute soft tissue injuries .
- Osteoporosis .
- Heart attack .
- Unstable angina pectoris .
- Implanted pacemaker or defibrillator .
- Pregnant women.
- Cancer .
- Rheumatoid arthritis.
- Connective tissue disease: This includes diseases such as osteomyelitis, lupus and scleroderma.
- Neurological conditions.
- \-
Key Trial Info
Start Date :
August 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 10 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06004076
Start Date
August 1 2023
End Date
February 10 2024
Last Update
August 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Physical Therapy Cairo University
Giza, Egypt